Living with and beyond cancer: The improvement story so far - NHS ...
Living with and beyond cancer: The improvement story so far - NHS ...
Living with and beyond cancer: The improvement story so far - NHS ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
28 | <strong>Living</strong> <strong>with</strong> <strong>and</strong> <strong>beyond</strong> <strong>cancer</strong>: <strong>The</strong> <strong>improvement</strong> <strong>story</strong> <strong>so</strong> <strong>far</strong><br />
Three Counties Cancer Network (3CCN) - Herefordshire<br />
‘Life After the Prostate’ group education programme<br />
for stable prostate <strong>cancer</strong> patients<br />
Summary<br />
Herefordshire is one of the three<br />
counties <strong>with</strong>in the 3 Counties Cancer<br />
Network (<strong>with</strong> Gloucestershire <strong>and</strong><br />
Worcestershire). This rural county has a<br />
population of 180,000 people served<br />
by Hereford County Hospital. <strong>The</strong><br />
urology service at the hospital currently<br />
sees approximately 200 new cases of<br />
prostate <strong>cancer</strong> each year. An<br />
information course consisting of four<br />
sessions in a group setting was<br />
developed to replace the ongoing<br />
yearly clinical follow up for stable<br />
patients <strong>and</strong> ongoing monitoring of<br />
PSA at GP surgeries.<br />
<strong>The</strong> issues<br />
Members of the clinical urology team<br />
believed that <strong>so</strong>me patients <strong>with</strong> stable<br />
prostate <strong>cancer</strong> were receiving ongoing<br />
yearly follow up at the hospital when a<br />
‘non-medical’ intervention may have<br />
been more appropriate. It was al<strong>so</strong> felt<br />
that <strong>so</strong>me patients were discharged<br />
<strong>with</strong>out being fully informed on topics<br />
that were of concern to them, <strong>and</strong><br />
unaware of what, if anything, would<br />
‘happen next’.<br />
Current prostate <strong>cancer</strong> follow up pathway - Herefordshire<br />
Timeline<br />
Diagnostic<br />
treatment<br />
pathway<br />
Follow up<br />
pathway<br />
begins<br />
Surgical<br />
treatment<br />
completed<br />
Radiotx<br />
treatment<br />
completed<br />
Hormone<br />
responsive<br />
6 weeks 6 months<br />
Urology<br />
follow up<br />
<strong>with</strong> doctor<br />
Oncology<br />
follow up<br />
<strong>with</strong> doctor<br />
/CNS<br />
At any point along these pathways, patients<br />
<strong>with</strong> unstable PSA/SI return for reassessment<br />
6 monthly<br />
follow up<br />
<strong>with</strong> CNS<br />
6 monthly<br />
follow up<br />
<strong>with</strong> CNS<br />
6 monthly<br />
follow up<br />
<strong>with</strong> CNS<br />
3 years 5 years Ad<br />
infinitum<br />
Long-term<br />
monitoring<br />
plan<br />
Long-term<br />
monitoring<br />
plan<br />
Proposed prostate <strong>cancer</strong> follow up pathway - Herefordshire<br />
Timeline<br />
NEW PATHWAY<br />
Follow up<br />
pathway<br />
begins<br />
CURRENT PATHWAY<br />
6 weeks 6 months<br />
Annual community<br />
follow up <strong>with</strong> GP<br />
(PSA tested)<br />
6 month<br />
Annual<br />
3 years 5 years Ad<br />
infinitum<br />
What was done<br />
• Project steering group was set up in<br />
Hereford in April 2009 including<br />
representation from users<br />
• A half day process mapping event to<br />
map out the current patient pathway<br />
for patients <strong>with</strong> stable prostate<br />
<strong>cancer</strong> <strong>and</strong> design an altered<br />
pathway that reflected the proposed<br />
change in follow up provision <strong>with</strong><br />
the introduction of the Life After<br />
Prostate information programme<br />
Diagnostic<br />
treatment<br />
pathway<br />
Surgical<br />
treatment<br />
completed<br />
Radiotx<br />
treatment<br />
completed<br />
Hormone<br />
responsive<br />
Urology<br />
follow up<br />
<strong>with</strong> doctor<br />
Oncology<br />
follow up<br />
<strong>with</strong> doctor<br />
/CNS<br />
Assessment<br />
for group<br />
programme<br />
Assessment<br />
for group<br />
programme<br />
At any point along these pathways, patients<br />
<strong>with</strong> unstable PSA/SI return for reassessment<br />
Group<br />
programme<br />
Current<br />
pathway<br />
Group<br />
programme<br />
Current<br />
pathway<br />
6 monthly<br />
follow up<br />
<strong>with</strong> CNS<br />
Group<br />
programme<br />
(4 weekly<br />
sessions)<br />
6 monthly<br />
follow up<br />
<strong>with</strong> CNS<br />
Long-term<br />
monitoring<br />
plan<br />
6 month follow up<br />
Group sessions<br />
Annual community<br />
follow up <strong>with</strong> GP<br />
(PSA tested)<br />
6 month<br />
Annual